Cover Image

3H-1,2-Benzoxaphosphepine 2-oxides as selective inhibitors of carbonic anhydrase IX and XII

The synthesis of 3H-1,2-benzoxaphosphepine 2-oxides and evaluation of their inhibitory activity against human carbonic anhydrase (hCA) isoforms I, II, IX, and XII are described. The target compounds were obtained via a concise synthesis from commercial salicylaldehydes and displayed low to sub-micro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aleksandrs Pustenko (Author), Anastasija Balašova (Author), Alessio Nocentini (Author), Claudiu T. Supuran (Author), Raivis Žalubovskis (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII
by: Anastasija Balašova, et al.
Published: (2023)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II
by: Jekaterīna Ivanova, et al.
Published: (2023)

The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2017)

1,2,3-Benzoxathiazine-2,2-dioxides - effective inhibitors of human carbonic anhydrases
by: Jekaterina Ivanova, et al.
Published: (2023)

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
by: Mikhail Krasavin, et al.
Published: (2020)

2-((1H-Benzo[d]imidazol-2-yl)amino)benzo[d]thiazole-6-sulphonamides: a class of carbonic anhydrase II and VII-selective inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
by: Adel S. El-Azab, et al.
Published: (2020)

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
by: Zainab M. Elsayed, et al.
Published: (2023)

A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors
by: Rakia Abd Alhameed, et al.
Published: (2020)

Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
by: Mehmet Onyılmaz, et al.
Published: (2022)

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
by: Wagdy M. Eldehna, et al.
Published: (2022)

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
by: Mohamed A. Abdelrahman, et al.
Published: (2020)

Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors
by: Morteza Abdoli, et al.
Published: (2022)

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
by: Ashraf K. El-Damasy, et al.
Published: (2023)

An overview on the recently discovered iota-carbonic anhydrases
by: Alessio Nocentini, et al.
Published: (2021)

Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives
by: Rita Meleddu, et al.
Published: (2021)

2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms
by: Lisa Sequeira, et al.
Published: (2023)

Novel thiazolone-benzenesulphonamide inhibitors of human and bacterial carbonic anhydrases
by: Morteza Abdoli, et al.
Published: (2023)

Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity
by: Haytham O. Tawfik, et al.
Published: (2022)

Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide-hydantoin hybrids
by: Morteza Abdoli, et al.
Published: (2024)

The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX
by: Zainab Saad Yusuf, et al.
Published: (2022)

Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
by: Tarfah Al-Warhi, et al.
Published: (2022)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
by: Sara Seršen, et al.
Published: (2019)

Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies
by: Ciro Milite, et al.
Published: (2019)

Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents
by: Mikhail Krasavin, et al.
Published: (2020)

Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii
by: Sonia Del Prete, et al.
Published: (2020)

Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
by: Alessio Nocentini, et al.
Published: (2021)

Carbonic anhydrase IX as a novel candidate in liquid biopsy
by: Ozen Ozensoy Guler, et al.
Published: (2020)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
by: Nora Astrain-Redin, et al.
Published: (2023)

Pyrrolyl and Indolyl α-γ-Diketo Acid Derivatives Acting as Selective Inhibitors of Human Carbonic Anhydrases IX and XII
by: Davide Ialongo, et al.
Published: (2023)

Carbonic Anhydrase Inhibitors as Novel Antibacterials in the Era of Antibiotic Resistance: Where Are We Now?
by: Alessio Nocentini, et al.
Published: (2023)

Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
by: Zhengxing Zhang, et al.
Published: (2017)

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
by: Chiara Testa, et al.
Published: (2022)

The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII
by: Alessandro Bonardi, et al.
Published: (2022)

Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold
by: Romeo Romagnoli, et al.
Published: (2023)